Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
Market Analysis and Insights: Global Tizanidine Market
The global Tizanidine market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
Global Tizanidine Scope and Market Size
Tizanidine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tizanidine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Segment by Application
Kids
Adults
By Company
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Market Analysis and Insights: Global Tizanidine Market
The global Tizanidine market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
Global Tizanidine Scope and Market Size
Tizanidine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tizanidine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Segment by Application
Kids
Adults
By Company
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
